Irene Hollfinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irene Hollfinger has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Holger Gerhardt
Integrative Vascular Biology Laboratory, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin 13125, Germany
3 shared publications - Christoph Harms
Department of Neurology with Experimental Neurology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
2 shared publications - Janet Lips
Klinik und Hochschulambulanz für Neurologie mit Experimenteller Neurologie, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health
2 shared publications - Jennifer Paech
Integrative Vascular Biology Laboratory, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin 13125, Germany
2 shared publications - Monika Dopatka
Klinik und Hochschulambulanz für Neurologie mit Experimenteller Neurologie, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health
2 shared publications - Stefanie Mayer
Klinik und Hochschulambulanz für Neurologie mit Experimenteller Neurologie, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health
2 shared publications
Latest Publications
- Open Access
Tunable Laminar Perfusion Coordinates Endothelial and Perivascular Remodeling in Angiogenic Vasculature-on-Chip
Perfusable vascular microphysiological systems are increasingly used to model angiogenesis, tissue crosstalk, and disease. However, many platforms still rely on oscillatory, discontinuous, or poorly controlled perfusion regimes, limiting the study of sustained flow-dependent vascular remodeling. Here, we establish a tunable, unidirectional laminar flow workflow for long-term perfusion of angiogenic vasculature-on-chip cultures and use it to investigate endothelial, perivascular, and immune cell responses to sustained flow. Using an AIM Biotech microfluidic platform containing 14-day-old human umbilical vein endothelial cell-derived angiogenic sprouts and pericytes, continuous perfusion enabled intraluminal transport of 1 μm tracer beads through vessels, demonstrating stable flow across the vascular bed. Sustained laminar flow induced endothelial remodeling at both the mother vessel and sprout levels, with cellular alignment evident in both compartments. Quantitative analysis of the mother vessel further revealed Golgi polarization against the direction of flow. Sustained perfusion also increased pericyte recruitment to angiogenic sprouts and reduced endothelial proliferation within the mother vessel, consistent with flow-driven vascular maturation and quiescence. Live-cell imaging further captured directional endothelial migration against the flow, lumen remodeling, and dynamic pericyte behavior under continuous perfusion. In immune-cell assays performed under continuous-flow conditions, interactions with untreated endothelium were limited, whereas inflammatory activation increased immune-cell adhesion and crawling. These observations suggest that sustained flow supports a quiescent endothelial phenotype and demonstrate the suitability of the platform for studying inflammatory activation and immune-vascular communication under controlled hemodynamic conditions. Beyond its biological relevance, the workflow provides practical advantages for live-cell imaging, low medium consumption, and downstream perturbation studies. Moreover, the modular design of the platform makes it well suited for vascular-organ crosstalk applications. Collectively, these results establish laminar flow angiogenic vasculature-on-chip as an experimentally tractable model for studying vascular mechanobiology, vascular maturation, and dynamic cell interactions under defined hemodynamic conditions.
Open AccessTunable Laminar Perfusion Coordinates Endothelial and Perivascular Remodeling in Angiogenic Vasculature-on-Chip
Perfusable vascular microphysiological systems are increasingly used to model angiogenesis, tissue crosstalk, and disease. However, many platforms still rely on oscillatory, discontinuous, or poorly controlled perfusion regimes, limiting the study of sustained flow-dependent vascular remodeling. Here, we establish a tunable, unidirectional laminar flow workflow for long-term perfusion of angiogenic vasculature-on-chip cultures and use it to investigate endothelial, perivascular, and immune cell responses to sustained flow. Using an AIM Biotech microfluidic platform containing 14-day-old human umbilical vein endothelial cell-derived angiogenic sprouts and pericytes, continuous perfusion enabled intraluminal transport of 1 μm tracer beads through vessels, demonstrating stable flow across the vascular bed. Sustained laminar flow induced endothelial remodeling at both the mother vessel and sprout levels, with cellular alignment evident in both compartments. Quantitative analysis of the mother vessel further revealed Golgi polarization against the direction of flow. Sustained perfusion also increased pericyte recruitment to angiogenic sprouts and reduced endothelial proliferation within the mother vessel, consistent with flow-driven vascular maturation and quiescence. Live-cell imaging further captured directional endothelial migration against the flow, lumen remodeling, and dynamic pericyte behavior under continuous perfusion. In immune-cell assays performed under continuous-flow conditions, interactions with untreated endothelium were limited, whereas inflammatory activation increased immune-cell adhesion and crawling. These observations suggest that sustained flow supports a quiescent endothelial phenotype and demonstrate the suitability of the platform for studying inflammatory activation and immune-vascular communication under controlled hemodynamic conditions. Beyond its biological relevance, the workflow provides practical advantages for live-cell imaging, low medium consumption, and downstream perturbation studies. Moreover, the modular design of the platform makes it well suited for vascular-organ crosstalk applications. Collectively, these results establish laminar flow angiogenic vasculature-on-chip as an experimentally tractable model for studying vascular mechanobiology, vascular maturation, and dynamic cell interactions under defined hemodynamic conditions.
- Open Access
- 30 August 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 135 (6) , 671-684
Intramyocardial Sprouting Tip Cells Specify Coronary Arterialization
BACKGROUND: The elaborate patterning of coronary arteries critically supports the high metabolic activity of the beating heart. How coronary endothelial cells coordinate hierarchical vascular remodeling and achieve arteriovenous specification remains largely unknown. Understanding the molecular and cellular cues that pattern coronary arteries is crucial to develop innovative therapeutic strategies that restore functional perfusion within the ischemic heart. METHODS: Single-cell transcriptomics and histological validation were used to delineate heterogeneous transcriptional states of the developing and mature coronary endothelium with a focus on sprouting endothelium and arterial cell specification. Genetic lineage tracing and high-resolution 3-dimensional imaging were used to characterize the origin and mechanisms of coronary angiogenic sprouting, as well as to fate-map selective endothelial lineages. Integration of single-cell transcriptomic data from ischemic adult mouse hearts and human embryonic data served to assess the conservation of transcriptional states across development, disease, and species. RESULTS: We discover that coronary arteries originate from cells that have previously transitioned through a specific tip cell phenotype. We identify nonoverlapping intramyocardial and subepicardial tip cell populations with differential gene expression profiles and regulatory pathways. Esm1 -lineage tracing confirmed that intramyocardial tip cells selectively contribute to coronary arteries and endocardial tunnels, but not veins. Notably, prearterial cells are detected from development stages to adulthood, increasingly in response to ischemic injury, and in human embryos, suggesting that tip cell-to-artery specification is a conserved mechanism. CONCLUSIONS: A tip cell-to-artery specification mechanism drives arterialization of the intramyocardial plexus and endocardial tunnels throughout life and is reactivated upon ischemic injury. Differential sprouting programs govern the formation and specification of the venous and arterial coronary plexus.
- 30 August 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 135 (6) , 671-684
Open AccessIntramyocardial Sprouting Tip Cells Specify Coronary Arterialization
BACKGROUND: The elaborate patterning of coronary arteries critically supports the high metabolic activity of the beating heart. How coronary endothelial cells coordinate hierarchical vascular remodeling and achieve arteriovenous specification remains largely unknown. Understanding the molecular and cellular cues that pattern coronary arteries is crucial to develop innovative therapeutic strategies that restore functional perfusion within the ischemic heart. METHODS: Single-cell transcriptomics and histological validation were used to delineate heterogeneous transcriptional states of the developing and mature coronary endothelium with a focus on sprouting endothelium and arterial cell specification. Genetic lineage tracing and high-resolution 3-dimensional imaging were used to characterize the origin and mechanisms of coronary angiogenic sprouting, as well as to fate-map selective endothelial lineages. Integration of single-cell transcriptomic data from ischemic adult mouse hearts and human embryonic data served to assess the conservation of transcriptional states across development, disease, and species. RESULTS: We discover that coronary arteries originate from cells that have previously transitioned through a specific tip cell phenotype. We identify nonoverlapping intramyocardial and subepicardial tip cell populations with differential gene expression profiles and regulatory pathways. Esm1 -lineage tracing confirmed that intramyocardial tip cells selectively contribute to coronary arteries and endocardial tunnels, but not veins. Notably, prearterial cells are detected from development stages to adulthood, increasingly in response to ischemic injury, and in human embryos, suggesting that tip cell-to-artery specification is a conserved mechanism. CONCLUSIONS: A tip cell-to-artery specification mechanism drives arterialization of the intramyocardial plexus and endocardial tunnels throughout life and is reactivated upon ischemic injury. Differential sprouting programs govern the formation and specification of the venous and arterial coronary plexus.
- Open Access
- 6 February 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Pial collaterals develop through mosaic colonization of capillaries by arterial and microvascular endothelial cells
Collaterals are unique blood vessels present in many healthy tissues that cross-connect distal-end arterioles of adjacent arterial trees, thus providing alternate routes of perfusion. Stroke patients with superior pial collateral flow respond better to treatments and present with an overall improved prognostic outcome. However, how pial collaterals develop in the embryo and how they reactivate upon stroke remains unclear. Here, using lineage tracing in combination with three-dimensional imaging, we demonstrate that mouse embryos employ a novel mechanism to build pial collaterals, distinct from their outward remodeling following stroke. Endothelial cells (ECs) of arterial and microvascular origin invade already existing pre-collateral vascular structures in a process which we termed mosaic colonization. Arterialization of these pre-collateral vascular segments happens concurrently with mosaic colonization. Despite having a smaller proliferative capacity, embryonic arterial cells represent the majority of cells that migrate to form nascent collaterals; embryonic microvascular cells, despite their higher proliferative potential, form only about a quarter of collateral endothelial cells. Moreover, postnatal collateral growth relies much more on self-replenishment of arterial cells than on microvascular contribution. Following ischemic injury, pial collateral outward remodeling relies on local cell proliferation rather than recruitment of non-arterial cells. Together, these findings establish distinct cellular mechanisms underlying pial collateral development and ischemic remodeling, raising the prospect for future research to identify novel, collateral-specific therapeutic strategies for ischemic stroke.
- 6 February 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Open AccessPial collaterals develop through mosaic colonization of capillaries by arterial and microvascular endothelial cells
Collaterals are unique blood vessels present in many healthy tissues that cross-connect distal-end arterioles of adjacent arterial trees, thus providing alternate routes of perfusion. Stroke patients with superior pial collateral flow respond better to treatments and present with an overall improved prognostic outcome. However, how pial collaterals develop in the embryo and how they reactivate upon stroke remains unclear. Here, using lineage tracing in combination with three-dimensional imaging, we demonstrate that mouse embryos employ a novel mechanism to build pial collaterals, distinct from their outward remodeling following stroke. Endothelial cells (ECs) of arterial and microvascular origin invade already existing pre-collateral vascular structures in a process which we termed mosaic colonization. Arterialization of these pre-collateral vascular segments happens concurrently with mosaic colonization. Despite having a smaller proliferative capacity, embryonic arterial cells represent the majority of cells that migrate to form nascent collaterals; embryonic microvascular cells, despite their higher proliferative potential, form only about a quarter of collateral endothelial cells. Moreover, postnatal collateral growth relies much more on self-replenishment of arterial cells than on microvascular contribution. Following ischemic injury, pial collateral outward remodeling relies on local cell proliferation rather than recruitment of non-arterial cells. Together, these findings establish distinct cellular mechanisms underlying pial collateral development and ischemic remodeling, raising the prospect for future research to identify novel, collateral-specific therapeutic strategies for ischemic stroke.
- Open Access
Pial collaterals develop through mosaic colonization of capillaries by arterial and microvascular endothelial cells
Collaterals are unique blood vessels present in many healthy tissues that cross-connect distal-end arterioles of adjacent arterial trees, thus providing alternate routes of perfusion. Stroke patients with superior pial collateral flow respond better to treatments and present with an overall improved prognostic outcome. However, how pial collaterals develop in the embryo and how they reactivate upon stroke remains unclear. Here, using lineage tracing in combination with three-dimensional imaging, we demonstrate that mouse embryos employ a novel mechanism to build pial collaterals, distinct from their outward remodeling following stroke. Endothelial cells (ECs) of arterial and microvascular origin invade already existing pre-collateral vascular structures in a process which we termed mosaic colonization. Arterialization of these pre-collateral vascular segments happens concurrently with mosaic colonization. Despite having a smaller proliferative capacity, embryonic arterial cells represent the majority of cells that migrate to form nascent collaterals; embryonic microvascular cells, despite their higher proliferative potential, form only about a quarter of collateral endothelial cells. Moreover, postnatal collateral growth relies much more on self-replenishment of arterial cells than on microvascular contribution. Following ischemic injury, pial collateral outward remodeling relies on local cell proliferation rather than recruitment of non-arterial cells. Together, these findings establish distinct cellular mechanisms underlying pial collateral development and ischemic remodeling, raising the prospect for future research to identify novel, collateral-specific therapeutic strategies for ischemic stroke.
Open AccessPial collaterals develop through mosaic colonization of capillaries by arterial and microvascular endothelial cells
Collaterals are unique blood vessels present in many healthy tissues that cross-connect distal-end arterioles of adjacent arterial trees, thus providing alternate routes of perfusion. Stroke patients with superior pial collateral flow respond better to treatments and present with an overall improved prognostic outcome. However, how pial collaterals develop in the embryo and how they reactivate upon stroke remains unclear. Here, using lineage tracing in combination with three-dimensional imaging, we demonstrate that mouse embryos employ a novel mechanism to build pial collaterals, distinct from their outward remodeling following stroke. Endothelial cells (ECs) of arterial and microvascular origin invade already existing pre-collateral vascular structures in a process which we termed mosaic colonization. Arterialization of these pre-collateral vascular segments happens concurrently with mosaic colonization. Despite having a smaller proliferative capacity, embryonic arterial cells represent the majority of cells that migrate to form nascent collaterals; embryonic microvascular cells, despite their higher proliferative potential, form only about a quarter of collateral endothelial cells. Moreover, postnatal collateral growth relies much more on self-replenishment of arterial cells than on microvascular contribution. Following ischemic injury, pial collateral outward remodeling relies on local cell proliferation rather than recruitment of non-arterial cells. Together, these findings establish distinct cellular mechanisms underlying pial collateral development and ischemic remodeling, raising the prospect for future research to identify novel, collateral-specific therapeutic strategies for ischemic stroke.